ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT)
Report
- Report Number
- 2954310-2012-81817
- Event Type
- Injury
- Date Received
- January 17, 2013
- Date of Event
- January 1, 1999
- Report Date
- December 20, 2012
- Manufacturer
- GUIDANT ENDOVASCULAR SOLUTIONS
- Product Code
- MIH
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
ATTEMPTS TO OBTAIN ADD'L INFO AND CLARIFICATION REGARDING THE CLINICAL OBSERVATIONS MENTIONED AND INVOLVEMENT OF THE ANCURE PRODUCT FROM THE ARTICLE AUTHOR(S) WERE UNSUCCESSFUL. THE FINDINGS OF THE STUDY WERE SUMMARIZED IN THE ARTICLE: M.T. VOUTE, F.M. BASTOS GONCALVES, J.M. HENDRIKS, R. METZ, M.R.H.M. VAN SAMBEEK, B.E. MUHS, H.J.M. VERHAGEN. "TREATMENT OF POST-IMPLANTATION ANEURYSM GROWTH BY LAPAROSCOPIC SAC FENESTRATION: LONG-TERM RESULTS" EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY; 2012: 44; 40-44.
BOSTON SCIENTIFIC (FORMERLY GUIDANT) RECEIVED INFO VIA A REVIEW OF THE LITERATURE, A STUDY PERFORMED THAT DISCUSSED LONG TERM RESULTS OF TREATMENT OF POST-IMPLANTATION ANEURYSM GROWTH BY LAPAROSCOPIC SAC FENESTRATION. IN THIS STUDY, ONE PT WAS IDENTIFIED THAT WAS IMPLANTED WITH AN ANCURE ENDOGRAFT DEVICE 6.3 YEARS PRIOR. IT WAS NOTED THAT A TYPE II ENDOLEAK WAS OBSERVED WITH NO ANEURYSM GROWTH REPORTED. THE PT'S DISEASE AND PROGRESSED AND LED TO DILATATION OF A COMMON ILIAC ARTERY. THE LEAK WAS TREATED WITH AN ILIAC EXTENSION. NO ADVERSE PT EFFECTS WERE REPORTED AS A RESULT OF THE ADD'L PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 25548 | ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT) | GRAFT | MIH | GUIDANT ENDOVASCULAR SOLUTIONS | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Hospitalization| L| R |